1. P03.02 A mutated prostatic acid phosphatase (PAP) peptide-based vaccine induces PAP-specific CD8+ T cells with ex vivo cytotoxic capacities in HHDII/DR1 transgenic mice. (21st September 2022) Authors: Thomas, JE; McArdle, S; Christensen, D; LeVu, P Journal: Journal for immunotherapy of cancer Issue: Volume 10(2022)Supplement 1 Page Start: A17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗